The symptoms of AD can be generally divided into three categories – cognitive, functional, and neuropsychiatric. The main areas of cognition that can be impaired during AD include memory, language, attention and executive functions, and visuospatial skills.
A decline in everyday function is also a predominant feature of AD, the effects of which become more disabling as the disease progresses. The ability to perform activities of daily living deteriorates with advancing disease severity.
Neuropsychiatric and behavioural symptoms of AD include depression/dysphoria, apathy/indifference, elation/euphoria, anxiety, irritability, agitation/aggression, aberrant motor behaviour, disinhibition, delusions, hallucinations, sleep disturbances, and appetite/eating disturbances.
Read more about The symptoms throughout the Alzheimer’s disease
Related content
Advances in blood biomarkers are transforming the diagnosis and prognosis of Alzheimer’s disease, helping to assess pathology, disease progression, and co-existing pathologies.
Overview of how blood-based biomarkers may support screening, diagnosis, staging, prognosis, and treatment decisions across the Alzheimer’s disease continuum.
Overview of a plasma biomarker testing pathway for symptomatic Alzheimer’s disease, using p-tau217 and eMTBR-tau243 to guide diagnostic assessment and identify underlying pathology.